Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Colli-Pee postal kits for home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Latest news

Novosanis research grant

Novosanis is offering a research grant in collaboration with EACR to stimulate innovative research in cancer biomarker detection using urine as a sample type. Urine can be collected in an easy, quick and non-invasive way, and has shown potential to change the way cancer is detected and monitored...

Latest blogpost

Vaccines play a critical role in protecting people against disease. HPV vaccination is primarily used for young girls, but is also recommended for boys. This blog explains the potential of HPV vaccination in reducing HPV-related cancers for girls and boys.

Upcoming event

ISLB 2021

ISLB 2021

Novosanis is excited to present a booth at ISLB, an international conference focusing on liquid biopsy. The congress takes place virtually on 22 October. Our team is excited to share the potential of urine as a liquid biopsy, especially in the field of oncology, during a presentation at the...